Skip to main content
Veterinary Medicines

CONOFITE GOTAS OTICAS Y SUSPENSION CUTANEA

Authorised
  • POLYMYXIN B SULFATE
  • Prednisolone acetate
  • Miconazole nitrate

Product identification

Medicine name:
CONOFITE GOTAS OTICAS Y SUSPENSION CUTANEA
Active substance:
  • POLYMYXIN B SULFATE
  • Prednisolone acetate
  • Miconazole nitrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Cutaneous use
  • Auricular use

Product details

Active substance and strength:
  • POLYMYXIN B SULFATE
    5500.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Prednisolone acetate
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Miconazole nitrate
    23.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous suspension
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
    • Cat
  • Auricular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar Veterinaria S.L.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Esteve Pharmaceuticals S.A.
  • Divasa Farmavic S.A.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 2347 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/12/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 10/02/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/12/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."